Literature DB >> 21183784

Charting the course across the blood-brain barrier.

David Nathanson1, Paul S Mischel.   

Abstract

The blood-brain barrier (BBB) presents a significant obstacle to delivery of targeted therapies to brain tumors. In this issue of the JCI, Staquicini and colleagues apply an in vivo phage-displayed library of random peptides to identify differentially expressed peptides that can be used to transport targeted agents across the intact BBB. The authors uncover a non-canonical, peptide-mediated iron-mimicry mechanism to induce transport of the transferrin/transferrin receptor complex across the BBB. They then demonstrate the ability of phage-targeting approaches to deliver therapeutic cargo and molecular imaging reporters across the BBB in an intracranial glioblastoma mouse model.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21183784      PMCID: PMC3007172          DOI: 10.1172/JCI45758

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  20 in total

1.  Ligand-directed surface profiling of human cancer cells with combinatorial peptide libraries.

Authors:  Mikhail G Kolonin; Laura Bover; Jessica Sun; Amado J Zurita; Kim-Anh Do; Johanna Lahdenranta; Marina Cardó-Vila; Ricardo J Giordano; Diana E Jaalouk; Michael G Ozawa; Catherine A Moya; Glauco R Souza; Fernanda I Staquicini; Akihiko Kunyiasu; Dominic A Scudiero; Susan L Holbeck; Edward A Sausville; Wadih Arap; Renata Pasqualini
Journal:  Cancer Res       Date:  2006-01-01       Impact factor: 12.701

Review 2.  Blood-brain barrier delivery.

Authors:  William M Pardridge
Journal:  Drug Discov Today       Date:  2006-11-13       Impact factor: 7.851

3.  Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubicin) in intracranial brain tumor xenografts.

Authors:  Yoji Yamashita; Michal T Krauze; Tomohiro Kawaguchi; Charles O Noble; Daryl C Drummond; John W Park; Krystof S Bankiewicz
Journal:  Neuro Oncol       Date:  2006-10-03       Impact factor: 12.300

Review 4.  PI3K signaling in glioma--animal models and therapeutic challenges.

Authors:  Christine K Cheng; Qi-Wen Fan; William A Weiss
Journal:  Brain Pathol       Date:  2009-01       Impact factor: 6.508

Review 5.  Replication-competent retrovirus vectors for cancer gene therapy.

Authors:  Chien-Kuo Tai; Noriyuki Kasahara
Journal:  Front Biosci       Date:  2008-01-01

Review 6.  Image-guided convection-enhanced delivery platform in the treatment of neurological diseases.

Authors:  Massimo S Fiandaca; John R Forsayeth; Peter J Dickinson; Krystof S Bankiewicz
Journal:  Neurotherapeutics       Date:  2008-01       Impact factor: 7.620

7.  Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface.

Authors:  G P Smith
Journal:  Science       Date:  1985-06-14       Impact factor: 47.728

8.  Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer.

Authors:  Yun Zhang; Yu-Feng Zhang; Joshua Bryant; Andrew Charles; Ruben J Boado; William M Pardridge
Journal:  Clin Cancer Res       Date:  2004-06-01       Impact factor: 12.531

9.  An integrated genomic analysis of human glioblastoma multiforme.

Authors:  D Williams Parsons; Siân Jones; Xiaosong Zhang; Jimmy Cheng-Ho Lin; Rebecca J Leary; Philipp Angenendt; Parminder Mankoo; Hannah Carter; I-Mei Siu; Gary L Gallia; Alessandro Olivi; Roger McLendon; B Ahmed Rasheed; Stephen Keir; Tatiana Nikolskaya; Yuri Nikolsky; Dana A Busam; Hanna Tekleab; Luis A Diaz; James Hartigan; Doug R Smith; Robert L Strausberg; Suely Kazue Nagahashi Marie; Sueli Mieko Oba Shinjo; Hai Yan; Gregory J Riggins; Darell D Bigner; Rachel Karchin; Nick Papadopoulos; Giovanni Parmigiani; Bert Vogelstein; Victor E Velculescu; Kenneth W Kinzler
Journal:  Science       Date:  2008-09-04       Impact factor: 47.728

10.  Comprehensive genomic characterization defines human glioblastoma genes and core pathways.

Authors: 
Journal:  Nature       Date:  2008-09-04       Impact factor: 49.962

View more
  13 in total

1.  Antitumor effects of minodronate, a third-generation nitrogen-containing bisphosphonate, in synergy with γδT cells in human glioblastoma in vitro and in vivo.

Authors:  Tsutomu Nakazawa; Mitsutoshi Nakamura; Ryosuke Matsuda; Fumihiko Nishimura; Young Soo Park; Yasushi Motoyama; Yasuo Hironaka; Ichiro Nakagawa; Hiroshi Yokota; Shuichi Yamada; Kentaro Tamura; Yasuhiro Takeshima; Kouji Omoto; Yoshitaka Tanaka; Yukiteru Ouji; Masahide Yoshikawa; Takahiro Tsujimura; Hiroyuki Nakase
Journal:  J Neurooncol       Date:  2016-07-08       Impact factor: 4.130

2.  Targeted delivery of proteins into the central nervous system mediated by rabies virus glycoprotein-derived peptide.

Authors:  Ailing Fu; Yilin Wang; Liping Zhan; Rumei Zhou
Journal:  Pharm Res       Date:  2012-01-10       Impact factor: 4.200

3.  MSK1-Mediated β-Catenin Phosphorylation Confers Resistance to PI3K/mTOR Inhibitors in Glioblastoma.

Authors:  Shaofang Wu; Shuzhen Wang; Siyuan Zheng; Roel Verhaak; Dimpy Koul; W K Alfred Yung
Journal:  Mol Cancer Ther       Date:  2016-04-22       Impact factor: 6.261

4.  Cytotoxic human peripheral blood-derived γδT cells kill glioblastoma cell lines: implications for cell-based immunotherapy for patients with glioblastoma.

Authors:  Tsutomu Nakazawa; Mitsutoshi Nakamura; Young Soo Park; Yasushi Motoyama; Yasuo Hironaka; Fumihiko Nishimura; Ichiro Nakagawa; Shuichi Yamada; Ryosuke Matsuda; Kentaro Tamura; Tadashi Sugimoto; Yasuhiro Takeshima; Akiko Marutani; Takahiro Tsujimura; Noriko Ouji; Yukiteru Ouji; Masahide Yoshikawa; Hiroyuki Nakase
Journal:  J Neurooncol       Date:  2013-09-24       Impact factor: 4.130

5.  Evaluation of the protective potential of brain microvascular endothelial cell autophagy on blood-brain barrier integrity during experimental cerebral ischemia-reperfusion injury.

Authors:  Haiying Li; Anju Gao; Dongxia Feng; Yang Wang; Li Zhang; Yonghua Cui; Bo Li; Zhong Wang; Gang Chen
Journal:  Transl Stroke Res       Date:  2014-07-30       Impact factor: 6.829

Review 6.  GBM's multifaceted landscape: highlighting regional and microenvironmental heterogeneity.

Authors:  Alenoush Vartanian; Sanjay K Singh; Sameer Agnihotri; Shahrzad Jalali; Kelly Burrell; Kenneth D Aldape; Gelareh Zadeh
Journal:  Neuro Oncol       Date:  2014-03-18       Impact factor: 12.300

Review 7.  Harnessing molecular recognition for localized drug delivery.

Authors:  Renjie Liu; Ran Zuo; Gregory A Hudalla
Journal:  Adv Drug Deliv Rev       Date:  2021-01-20       Impact factor: 15.470

8.  Persistent prolate polymersomes for enhanced co-delivery of hydrophilic and hydrophobic drugs.

Authors:  Nicholas L'Amoreaux; Aon Ali; Shoaib Iqbal; Jessica Larsen
Journal:  Nanotechnology       Date:  2020-01-15       Impact factor: 3.953

Review 9.  Drug delivery strategies to enhance the permeability of the blood-brain barrier for treatment of glioma.

Authors:  Fang Zhang; Chun-Lei Xu; Chun-Mei Liu
Journal:  Drug Des Devel Ther       Date:  2015-04-09       Impact factor: 4.162

10.  A tumor-targeting p53 nanodelivery system limits chemoresistance to temozolomide prolonging survival in a mouse model of glioblastoma multiforme.

Authors:  Sang-Soo Kim; Antonina Rait; Eric Kim; Kathleen F Pirollo; Esther H Chang
Journal:  Nanomedicine       Date:  2014-09-18       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.